Newsbenzinga
Aquestive Therapeutics Announces Resubmission Of NDA To FDA For Anaphylm Sublingual Film For Type I Allergic Reactions
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…